Too early to bet against AI trade, State Street suggests

State Street's Chief Business Officer Anna Paglia maintains a bullish stance on AI and momentum stocks, arguing investors will continue to favor growth despite the Nasdaq's recent decline and a 4% pullback in their SPDR NYSE Technology ETF last week, anticipating any significant rebalancing or diversification focus only early next year. Conversely, Todd Rosenbluth points to an emerging market rotation, citing the Health Care Select Sector SPDR Fund's 5% gain since October 1st and its strong performance this week as evidence of a shift towards defensive sectors.

Analysis

State Street's Chief Business Officer, Anna Paglia, reiterates a bullish stance on AI and momentum stocks, despite the Nasdaq's recent worst week since April. She asserts that investors remain committed to the growth narrative, evidenced by the SPDR NYSE Technology ETF (XNTK)'s 38% year-to-date gain. However, XNTK experienced a >4% pullback last week, with its top holding, Palantir Technologies (PLTR), tumbling >11% post-earnings, signaling recent profit-taking in the sector.

This view contrasts with Todd Rosenbluth's assessment, who observes an emerging market rotation towards defensive sectors. He points to the Health Care Select Sector SPDR Fund (XLV), which gained 5% since October 1st and was the second-best performing S&P 500 group this week, as evidence of investors diversifying away from technology. This shift suggests a potential re-evaluation of market leadership.

Paglia anticipates a cooling off in the tech space and a focus on diversification only early next year, implying short-term momentum persistence. The divergence in analyst opinions, coupled with mixed market signals (strong YTD tech gains versus recent pullbacks and defensive sector outperformance), highlights a period of uncertainty regarding sustained market leadership.

Key Decisions for Investors

• Investors should closely monitor the durability of the AI and momentum trade, particularly in light of recent profit-taking in technology-linked names and the Nasdaq's short-term weakness.
• Evaluate the potential for a sustained sector rotation into defensive areas like healthcare, considering its recent outperformance and historical role as a hedge against market volatility.
• Consider strategically rebalancing portfolios to incorporate diversification into less growth-dependent sectors, aligning with the anticipated market rebalancing early next year.